At the forefront of exciting new research to find better treatment for childhood cancer
The principal aim of the Doernbecher Children’s Hospital Development Therapeutics program is to evaluate novel agents for the treatment of pediatric cancer through early phase clinical trials. We conduct Phase I and Phase II trials of potentially promising new drugs for the treatment of all types of childhood cancer. Doernbecher is one of 21 select institutions in North America who comprise the NCI-funded Children’s Oncology Group Phase I Consortium. Through our participation in COG early … Read More
Recent Comments
- Cecily on Kids Making Miracles founder believes ‘kids can do things adults can’t.’
- Anne Bell-Fysh on ‘My Pregnancy Plate’: a blueprint for healthy eating during pregnancy
- Anne Bell-Fysh on ‘My Pregnancy Plate’: a blueprint for healthy eating during pregnancy
- Kiara on ‘My Pregnancy Plate’: a blueprint for healthy eating during pregnancy
- Barbara George on ‘My Pregnancy Plate’: a blueprint for healthy eating during pregnancy
More Comments